Therapeutic Options To Refractory Alopecia Areata
January 2023
in “
International journal of medical science and clinical research studies
”
TLDR Treating stubborn hair loss involves both medical and emotional support options.
The document "Therapeutic Options to Refractory Alopecia Areata" reviews various treatments for alopecia areata, focusing on immune and inflammatory indicators, patient experiences, and the efficacy of different medications. Key treatments discussed include JAK inhibitors, such as ruxolitinib, which have shown promise in inducing hair regrowth in patients with moderate-to-severe alopecia areata. The review also covers the safety and effectiveness of other therapies like cyclosporine, minoxidil, spironolactone, and azathioprine. Additionally, it highlights the importance of understanding patient experiences and the need for personalized treatment approaches.